ZWI Therapeutics, Inc. — Form D/A
ZWI Therapeutics, Inc. of WATERTOWN, MA, a company, filed a Form D amendment with the SEC on 2022-12-23. The offering totals $10.0M. Industry: Biotechnology.
Offering
- Filed: 2022-12-23
- Form: D/A
- Accession: 0001854359-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Remaining: $10.0M
- Investors: 2
- Date of first sale: 2021-03-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-394203
Issuer
- Name: ZWI Therapeutics, Inc.
- CIK: 0001854359
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 199 DEXTER AVENUE, WATERTOWN, MA, 02472
- Phone: 781-801-6172
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| XIN HUANG | Director | Watertown, MA |
| SHAOYI JIANG | Director | Watertown, MA |
| ANDREW KEEFE | Director | Watertown, MA |
| Robert Langer | Director | Pittsburgh, PA |
| CHENG XING | Director | Watertown, MA |
| ANDREW KEEFE | Executive Officer | Watertown, MA |
Other filings by this issuer (1)
More